Opendata, web and dolomites

PATHOLYTIX-GI

PATHOLYTIX: Using Artificial Intelligence to Transform Clinical Diagnostic Pathology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PATHOLYTIX-GI project word cloud

Explore the words cloud of the PATHOLYTIX-GI project. It provides you a very rough idea of what is the project "PATHOLYTIX-GI" about.

fit    cell    cancer    patients    components    faces    microscope    diseases    additional    competition    aided    data    clinics    millions    solution    hence    becomes    clinical    perform    efficient    pathologists    reducing    direct    revolutionize    expert    costly    techniques    cad    sme    intelligence    medical    framework    pathological    individual    irish    population    decreasing    knock    worldwide    deciphex    tissue    workflow    interface    trained    industry    pathologist    alleviate    feasibility    validation    competitors    routine    extensive    instrument    big    laborious    artificial    undergo    patholytix    coupled    crises    hundreds    transforming    prevalence    types    tissues    pathology    markets    preliminary    company    uses    prototype    tool    centuries    performed    purpose    innovative    soaring    ltd    market    pilot    global    biopsies    reduce    hospitals    effect    productivity    diagnosis    automate    streamline    leader    computer    regards   

Project "PATHOLYTIX-GI" data sheet

The following table provides information about the project.

Coordinator
DECIPHEX LIMITED 

Organization address
address: 7 GARRAI NA GCRANN
city: MORNINGTON MEATH
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.deciphex.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECIPHEX LIMITED IE (MORNINGTON MEATH) coordinator 50˙000.00

Map

 Project objective

Routine diagnosis on biopsies and tissues is performed by expert pathologists. However, the pathology sector faces a major crises, due to soaring numbers of biopsies for diagnosis, coupled with decreasing numbers of trained pathologists, which is affecting patients. Technology can alleviate this crises by using computer aided diagnosis (CAD) to increase productivity, reduce costs and streamline workflow.

Deciphex Ltd is an Irish company developing an innovative Computer Aided Diagnosis (CAD) system which will revolutionize the medical diagnosis pathology sector. Our ‘PATHOLYTIX’ system uses state-of-the-art artificial intelligence techniques to automate the laborious and costly pathology assessment (currently done via microscope). By transforming this centuries old clinical practice, we aim to become a market leader in new CAD industry.

We currently have prototype technology and preliminary data, to identify different tissue and cell types. In this feasibility study we will perform pilot studies in a US based clinical pathologist, to demonstrate our tool can identify various diseases. In Phase 2 of the SME Instrument, we will undergo additional development, extensive validation, and build the data management framework and user interface.

There is a large global target market for PATHOLYTIX, which is growing each year driven by an increasing population and higher prevalence of diseases (such as cancer). Hence hospitals and clinics worldwide process hundreds of millions of biopsies per year. With regards to competitors, there is no direct competition. Competitors offer individual components of the pathological workflow, not fit-for-purpose solution like PATHOLYTIX.

Overall, PATHOLYTIX would have a big impact on the pathology sector, by increasing productivity and reducing costs. This should have a knock on effect for the global and EU markets, particularly for patients as diagnosis becomes more efficient.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PATHOLYTIX-GI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PATHOLYTIX-GI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More